Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis of two phase 3 randomized clinical trials.
David B ClemowSimin K BayganiPaula M HauckCory B HultmanPublished in: Current medical research and opinion (2020)
The efficacy and safety of lasmiditan for treatment of individual migraine attacks appear to be independent of comorbid conditions.
Keyphrases